Sangiovanni Timothy J.'s Form 4 filing
Zevra Therapeutics, Inc. (ZVRA) · filed Mar 13, 2023
- Accession no.
- 0001437749-23-006278
- Filed
- Mar 13, 2023
- Trade date
- Mar 10, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.97K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sangiovanni Timothy J.CIK 0001698328 | Officer (SVP, Corporate Controller) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | Common Stock | PPurchaseAcquired | +1,100 | $4.14 | +$4,554 | 4,349 | Direct | |
| Mar 10, 2023 | Common Stock | PPurchaseAcquired | +100 | $4.14 | +$414 | 4,449 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.